May some HCV genotype 1 patients still benefit from dual therapy? The role of very early HCV kinetics.
Tontodonati M, Cento V, Polilli E, Colabattista C, Cascella R, Sciotti M, Di Giammartino D, Trave F, Di Maio VC, Monarca R, Di Candilo F, Prinapori R, Rastrelli E, Vecchiet J, Ceccherini-Silberstein F, Manzoli L, Giardina E, Perno CF, Parruti G.
Tontodonati M, et al. Among authors: giardina e.
New Microbiol. 2015 Oct;38(4):491-7. Epub 2015 Oct 20.
New Microbiol. 2015.
PMID: 26485008
Free article.
Clinical Trial.